Special articleObesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide
Abbreviations and Acronyms
ACE
angiotensin-converting enzyme
ACEi
angiotensin-converting enzyme inhibitor
AF
atrial fibrillation
Ang II
angiotensin II
ARB
angiotensin receptor blocker
BMI
body mass index
CHD
coronary heart disease
CKD
chronic kidney disease
COVID-19
coronavirus disease 2019
CVD
cardiovascular disease
ET
exercise training
HF
heart failure
HTN
hypertension or hypertensive
MetS
metabolic syndrome
OR
odds ratio
PA
physical activity
RAAS
renin-angiotensin-aldosterone system
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
SNS
sympathetic nervous
T2DM
type 2 diabetes mellitus
VTE
venous thromboembolism
Cited by (0)
Grant Support: F.S.-G. is supported by a postdoctoral contract granted by “Subprograma Atracció de Talent - Contractes Postdoctorals de la Universitat de València.”
Potential Competing Interests: Dr Mehra reports consultancy with Abbott, Janssen, Roivant, Baim Institute for Clinical Research, Leviticus, FineHeart, NupulseCV, Portola, Bayer, Triple Gene, and Mesoblast. The other authors report no competing interests.
© 2020 Mayo Foundation for Medical Education and Research